Although the effects of metformin, DPP-4 inhibitors, and SGLT-2 inhibitors on migraine have not been specifically reported, the use of these medications has been associated with a lower risk of depression, a common comorbidity of migraine [33]. The gene discussed is SLC5A2; the disease is depressive symptom measurement.